Evidence map›Paper›PMID 19828789›Full record

ReviewThe Journal of neuroscience : the official journal of the Society for Neuroscience2009

Axonal transport defects in neurodegenerative diseases.

Gerardo A Morfini, Matthew Burns, Lester I Binder, Nicholas M Kanaan, Nichole LaPointe, Daryl A Bosco, Robert H Brown, Hannah Brown, Ashutosh Tiwari, Lawrence Hayward and 7 more

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 281 papers.

0numbers the graph read from it
0cells of the map it votes in
281citing papers in PubMed
23.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

281 citing papers in PubMed, 452 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Patient-derived forebrain cortical organoids reveal biphasic tau-MAP6-microtubule axis dysfunction in tauopathy.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

221 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 9 institutions in 4 countries.

Gerardo A MorfiniDepartment of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, Illinois 60612, USA. gmorfini@uic.edu
Matthew Burns
Lester I Binder
Nicholas M Kanaan
Nichole LaPointe
Daryl A Bosco
Robert H Brown
Hannah Brown
Ashutosh Tiwari
Lawrence Hayward
Julia Edgar
Klaus-Armin Nave
James Garberrn
Yuka Atagi
Yuyu Song
Gustavo Pigino
Scott T Brady
University of Illinois Chicago · USNorthwestern University · USUniversity of Massachusetts Chan Medical School · USInstitute of Cell Biology and Neurobiology · ITMassachusetts General Hospital · USMax Planck Institute of Experimental Medicine · DEMichigan Technological University · USUniversity of Glasgow · GBWayne State University · US

Funding

Tau Truncation & Conformation In Alzheimer's Disease ProgressionP01AG009466 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BINDER, LESTER IRVIN · 1991 to 2012
$14.3M
PREDOCTORAL AND POSTDOCTORAL TRAINING PROGRAM IN AGING AND DEMENTIAT32AG020506 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI ROBERT J VASSAR, SANDRA WEINTRAUB · 2002 to 2026
$9.9M
MOLECULAR MECHANISMS OF AXONAL TRANSPORTR01NS023868 · NINDS · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI BRADY, SCOTT THOMAS · 1986 to 2010
$3.7M
REGULATION OF FAST AXONAL TRANSPORT DIABETIC NEUROPATHYR01NS041170 · NINDS · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI BRADY, SCOTT THOMAS · 2000 to 2004
$1.6M
PROPERTIES OF AXONAL TUBULIN RELATED TO NEURONAL GROWTHR01NS023320 · NINDS · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI BRADY, SCOTT THOMAS · 1985 to 2003
$1.0M
Molecular Mechanisms of Axonal TransportR56NS023868 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BRADY, SCOTT THOMAS · 2011 to 2011
$554k
NIA NIH HHS AG09466NIA NIH HHS P01 AG009466NIA NIH HHS T32 AG020506NIA NIH HHS T32AG020506-07NINDS NIH HHS NS23320NINDS NIH HHS NS23868NINDS NIH HHS NS41170NINDS NIH HHS R01 NS023320NINDS NIH HHS R01 NS023868NINDS NIH HHS R01 NS041170NINDS NIH HHS R56 NS023868
6 · The paper itself

Abstract

Adult-onset neurodegenerative diseases (AONDs) comprise a heterogeneous group of neurological disorders characterized by a progressive, age-dependent decline in neuronal function and loss of selected neuronal populations. Alterations in synaptic function and axonal connectivity represent early and critical pathogenic events in AONDs, but molecular mechanisms underlying these defects remain elusive. The large size and complex subcellular architecture of neurons render them uniquely vulnerable to alterations in axonal transport (AT). Accordingly, deficits in AT have been documented in most AONDs, suggesting a common defect acquired through different pathogenic pathways. These observations suggest that many AONDs can be categorized as dysferopathies, diseases in which alterations in AT represent a critical component in pathogenesis. Topics here address various molecular mechanisms underlying alterations in AT in several AONDs. Illumination of such mechanisms provides a framework for the development of novel therapeutic strategies aimed to prevent axonal and synaptic dysfunction in several major AONDs.

Indexed as

Amyloid beta-PeptidesAnimalsAxonal TransportDisease Models, AnimalHumansMiceMicrotubule-Associated ProteinsModels, BiologicalNeurodegenerative DiseasesNeuronsSignal TransductionSynapsestau ProteinsAmyloid beta-PeptidesMicrotubule-Associated Proteinstau Proteins

Identifiers

PMID19828789
PMCPMC2801051
OpenAlexW2021258666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.